Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Vendor Neutral Archive (VNA) & PACS Market, by Product Type
1.4.2 North America Vendor Neutral Archive (VNA) & PACS Market, by Vendor Type
1.4.3 North America Vendor Neutral Archive (VNA) & PACS Market, by Deployment
1.4.4 North America Vendor Neutral Archive (VNA) & PACS Market, by End User
1.4.5 North America Vendor Neutral Archive (VNA) & PACS Market, by Application
1.4.6 North America Vendor Neutral Archive (VNA) & PACS Market, by Modality
1.4.7 North America Vendor Neutral Archive (VNA) & PACS Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2020, Aug – 2024, Feb) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. North America Vendor Neutral Archive (VNA) & PACS Market by Product Type
5.1 North America VNA Market by Region
5.2 North America Vendor Neutral Archive (VNA) & PACS Market by VNA Type
5.2.1 North America Multi-Department VNA Market by Country
5.2.2 North America Department VNA Market by Country
5.2.3 North America Multi-Site VNA Market by Country
5.3 North America PACS Market by Region
5.4 North America Vendor Neutral Archive (VNA) & PACS Market by PACS Type
5.4.1 North America Multi-Department PACS Market by Country
5.4.2 North America Department PACS Market by Country
5.4.3 North America Multi-Site PACS Market by Country
Chapter 6. North America Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
6.1 North America Independent Vendor Market by Region
6.2 North America Third-party Vendor Market by Region
Chapter 7. North America Vendor Neutral Archive (VNA) & PACS Market by Deployment
7.1 North America On-Premise Market by Country
7.2 North America Cloud-Based Market by Country
7.3 North America Hybrid Model Market by Country
Chapter 8. North America Vendor Neutral Archive (VNA) & PACS Market by End User
8.1 North America Hospitals & Clinics Market by Country
8.2 North America Diagnostic Centers Market by Country
8.3 North America Others Market by Country
Chapter 9. North America Vendor Neutral Archive (VNA) & PACS Market by Application
9.1 North America Cardiology Market by Country
9.2 North America Orthopedic Market by Country
9.3 North America Oncology Market by Country
9.4 North America Neurology Market by Country
9.5 North America Obstetrics & Gynecology Market by Country
9.6 North America Others Market by Country
Chapter 10. North America Vendor Neutral Archive (VNA) & PACS Market by Modality
10.1 North America Computed Tomography Market by Country
10.2 North America Mammography Market by Country
10.3 North America MRI Market by Country
10.4 North America Ultrasound Market by Country
10.5 North America X-Rays Market by Country
10.6 North America PET Market by Country
Chapter 11. North America Vendor Neutral Archive (VNA) & PACS Market by Country
11.1 US Vendor Neutral Archive (VNA) & PACS Market
11.1.1 US Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.1.1.1 US Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.1.1.2 US Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.1.2 US Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.1.3 US Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.1.4 US Vendor Neutral Archive (VNA) & PACS Market by End User
11.1.5 US Vendor Neutral Archive (VNA) & PACS Market by Application
11.1.6 US Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2 Canada Vendor Neutral Archive (VNA) & PACS Market
11.2.1 Canada Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.1.1 Canada Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.1.2 Canada Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.2 Canada Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.3 Canada Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.4 Canada Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.5 Canada Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.6 Canada Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3 Mexico Vendor Neutral Archive (VNA) & PACS Market
11.3.1 Mexico Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.1.1 Mexico Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.1.2 Mexico Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.2 Mexico Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.3 Mexico Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.4 Mexico Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.5 Mexico Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.6 Mexico Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4 Rest of North America Vendor Neutral Archive (VNA) & PACS Market
11.4.1 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.1.1 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.1.2 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.2 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.3 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.4 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.5 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.6 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Modality
Chapter 12. Company Profiles
12.1 Hyland Software, Inc.
12.1.1 Company Overview
12.1.2 Recent strategies and developments:
12.1.2.1 Partnerships, Collaborations, and Agreements:
12.1.2.2 Product Launches and Product Expansions:
12.2 GE HealthCare Technologies, Inc.
12.2.1 Company Overview
12.2.2 Financial Analysis
12.2.3 Segmental and Regional Analysis
12.2.4 Research & Development Expenses
12.2.5 Recent strategies and developments:
12.2.5.1 Partnerships, Collaborations, and Agreements:
12.2.6 SWOT Analysis
12.3 Koninklijke Philips N.V.
12.3.1 Company Overview
12.3.2 Financial Analysis
12.3.3 Segmental and Regional Analysis
12.3.4 Research & Development Expense
12.3.5 Recent strategies and developments:
12.3.5.1 Partnerships, Collaborations, and Agreements:
12.3.6 SWOT Analysis
12.4 Siemens Healthineers AG (Siemens AG)
12.4.1 Company Overview
12.4.2 Financial Analysis
12.4.3 Segmental and Regional Analysis
12.4.4 Research & Development Expense
12.4.5 Recent strategies and developments:
12.4.5.1 Partnerships, Collaborations, and Agreements:
12.4.6 SWOT Analysis
12.5 Fujifilm Holdings Corporation
12.5.1 Company Overview
12.5.2 Financial Analysis
12.5.3 Segmental and Regional Analysis
12.5.4 Research & Development Expenses
12.5.5 Recent strategies and developments:
12.5.5.1 Product Launches and Product Expansions:
12.5.5.2 Acquisition and Mergers:
12.5.6 SWOT Analysis
12.6 IBM Corporation
12.6.1 Company Overview
12.6.2 Financial Analysis
12.6.3 Regional & Segmental Analysis
12.6.4 Research & Development Expenses
12.6.5 Recent strategies and developments:
12.6.5.1 Product Launches and Product Expansions:
12.6.6 SWOT Analysis
12.7 Carestream Health, Inc. (Onex Corporation)
12.7.1 Company Overview
12.7.2 SWOT Analysis
12.8 Novarad Enterprise Healthcare Solutions
12.8.1 Company Overview
12.8.2 Recent strategies and developments:
12.8.2.1 Partnerships, Collaborations, and Agreements:
12.8.2.2 Product Launches and Product Expansions:
12.8.3 SWOT Analysis
12.9 Canon, Inc. (Canon Medical Systems Corporation)
12.9.1 Company Overview
12.9.2 Financial Analysis
12.9.3 Segmental and Regional Analysis
12.9.4 Research & Development Expenses
12.9.5 Recent strategies and developments:
12.9.5.1 Partnerships, Collaborations, and Agreements:
12.9.5.2 Product Launches and Product Expansions:
12.9.6 SWOT Analysis
12.10. INFINITT Healthcare Co. Ltd.
12.10.1 Company Overview
12.10.2 Recent strategies and developments:
12.10.2.1 Partnerships, Collaborations, and Agreements:
12.10.2.2 Product Launches and Product Expansions:
12.10.3 SWOT Analysis
Unique Offerings 